Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials. (2021)

First Author: Moran E

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(21)00464-3

PubMed Identifier: 34411531

Publication URI: http://europepmc.org/abstract/MED/34411531

Type: Journal Article/Review

Volume: 21

Parent Publication: The Lancet. Infectious diseases

Issue: 10

ISSN: 1473-3099